I have received all of my order plus the bonus pills. You not only met my
expectations but greatly exceeded them!
You properly set my expectations by providing me all the information that I would
need during the ordering process and then followed up regularly to insure that all
was occurring as it should.
Your focus on customer service is outstanding and has won me over as a long time
customer. I have already recommended you to two of my friends and will continue to
do so in the future. I am also very pleased with the quality of your product and
accompanying reference materials that I received with my order.
I will do all of my medical business through your firm from this point forward.
Thank you for your proactive efforts and strong customer focused business
practices. I can honestly say my purchase experience has been outstanding!
- Sincerely, Lloyd
Thigh fractures linked to osteoporosis drugs; long-term use questioned - Harvard Health Publications (blog)
KSBY San Luis Obispo NewsThigh fractures linked to osteoporosis drugs; long-term use questionedHarvard Health Publications (blog)Since bisphosphonates such as alendronate (Fosamax), ibandronate (Boniva), risedronate (Actonel), and zoledronic acid (Reclast) were first introduced in the mid-1990s, they've become a staple of osteoporosis treatment.
Long-term use of osteoporosis medication may reduce bone fracture risk for ... - Science Codex
Science CodexLong-term use of osteoporosis medication may reduce bone fracture risk for .
Long-term use of osteoporosis medication may reduce bone fracture risk for ... - Medical Xpress
Long-term use of osteoporosis medication may reduce bone fracture risk for .
New Cautions About Long-Term Use of Bone Drugs - New York Times (blog)
New York Times (blog)New Cautions About Long-Term Use of Bone DrugsNew York Times (blog)A study of Fosamax, which is sold generically as alendronate, continued for 10 years, and a study of Reclast, an injectable form of the drug zoledronic acid, continued for six years.
Aging Population, Growing Awareness and Novel Therapeutics Drives the Global ... - San Francisco Chronicle (press release)
Aging Population, Growing Awareness and Novel Therapeutics Drives the Global .